We are live on ! Find out more
WA

Wasatch Advisors Portfolio holdings

AUM $15.3B
1-Year Est. Return 25.06%
This Fund
S&P 500
This Quarter Est. Return
-0.45%
1 Year Est. Return
+25.06%
3 Year Est. Return
+87.66%
5 Year Est. Return
+80.4%
10 Year Est. Return
+874.7%
AUM
$15.8B
AUM Growth
-$692M
Cap. Flow
-$140M
Cap. Flow %
-0.89%
Top 10 Hldgs %
25.28%
Holding
274
New
17
Increased
112
Reduced
113
Closed
20

Top Sells

Rank Stock Value
1
EEFT icon
Euronet Worldwide
EEFT
+$182M
2
ZIP icon
ZipRecruiter
ZIP
+$160M
3
SAIA icon
Saia
SAIA
+$88.4M
4
TREX icon
Trex
TREX
+$77.8M
5
MEDP icon
Medpace
MEDP
+$76M

Sector Composition

Rank Sector Weight
1 Technology 27.01%
2 Consumer Discretionary 17%
3 Healthcare 17%
4 Industrials 14.93%
5 Financials 12.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNTG icon
126
Pennant Group
PNTG
$1.43B
$15.8M 0.1%
1,419,270
+75,633
+6% +$876K
ALNT icon
127
Allient
ALNT
$1.34B
$15.2M 0.1%
492,340
-18,619
-4% -$645K
DYN icon
128
Dyne Therapeutics
DYN
$4.15B
$15.1M 0.1%
1,687,802
-571,733
-25% -$6.16M
WEAV icon
129
Weave Communications
WEAV
$553M
$15M 0.09%
1,841,951
-225,814
-11% -$2.29M
FNA
130
DELISTED
Paragon 28, Inc.
FNA
$14.9M 0.09%
1,186,890
-67,774
-5% -$1.02M
BOOM icon
131
DMC Global
BOOM
$111M
$14.1M 0.09%
577,219
-64,433
-10% -$1.4M
AGYS icon
132
Agilysys
AGYS
$3.21B
$14M 0.09%
211,381
+24,338
+13% +$1.69M
KLRS
133
Kalaris Therapeutics
KLRS
$80.9M
$13.6M 0.09%
274,777
-14,097
-5% -$961K
RUSHA icon
134
Rush Enterprises Class A
RUSHA
$6.34B
$13.2M 0.08%
+323,151
New +$13.4M
ATRA icon
135
Atara Biotherapeutics
ATRA
$72.6M
$12.4M 0.08%
335,969
+4,610
+1% +$205K
KIDS icon
136
OrthoPediatrics
KIDS
$513M
$12.4M 0.08%
387,580
-18,076
-4% -$696K
CCCC icon
137
C4 Therapeutics
CCCC
$389M
$11.6M 0.07%
6,247,141
-952,350
-13% -$2.9M
XYZ
138
Block Inc
XYZ
$48.9B
$11.5M 0.07%
258,876
+43,340
+20% +$2.68M
ESPR
139
DELISTED
Esperion Therapeutics
ESPR
$11.3M 0.07%
11,526,100
-1,613,456
-12% -$2.33M
NSSC icon
140
Napco Security Technologies
NSSC
$1.3B
$11.2M 0.07%
504,241
+53,026
+12% +$1.61M
DCO icon
141
Ducommun
DCO
$2.56B
$10.8M 0.07%
+248,350
New +$11.3M
SGMO
142
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$10.8M 0.07%
17,986,781
+934,341
+5% +$1M
VKTX icon
143
Viking Therapeutics
VKTX
$3.88B
$10.7M 0.07%
963,264
-746,211
-44% -$10.7M
STRL icon
144
Sterling Infrastructure
STRL
$15.2B
$10.6M 0.07%
144,457
-109,643
-43% -$7.67M
HCI icon
145
HCI Group
HCI
$2.34B
$9.61M 0.06%
177,061
-16,688
-9% -$949K
CERS icon
146
Cerus
CERS
$575M
$9.51M 0.06%
5,873,048
CTLP
147
DELISTED
Cantaloupe
CTLP
$9.42M 0.06%
1,507,608
+2,244
+0.1% +$16.5K
RDVT icon
148
Red Violet
RDVT
$957M
$8.38M 0.05%
418,604
+9,148
+2% +$189K
XPOF icon
149
Xponential Fitness
XPOF
$286M
$8.16M 0.05%
526,766
+18,830
+4% +$369K
OSIS icon
150
OSI Systems
OSIS
$3.53B
$8.16M 0.05%
69,130
-9,879
-13% -$1.19M

Similar funds

Wasatch Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Wasatch Advisors held 274 positions worth $15.8B, down 4.2% from $16.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wasatch Advisors's Q3 2023 filing shows 17 new, 112 increased, 113 reduced and 20 closed positions. Its largest new stake was PowerSchool Holdings, Inc.: 3,114,315 shares worth $70.6M. The largest sale was Euronet Worldwide, an estimated $182M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Wasatch Advisors's largest Q3 2023 buy was PowerSchool Holdings, Inc.: 3,114,315 shares worth $70.6M.
  • Wasatch Advisors added most to Inspire Medical Systems in Q3 2023, an estimated $121M increase.
  • Wasatch Advisors's biggest Q3 2023 reduction was Euronet Worldwide, cutting an estimated $182M.
  • Wasatch Advisors fully exited ZipRecruiter in Q3 2023, selling an estimated $160M.
  • Wasatch Advisors's ten largest holdings make up 25% of its $15.8B portfolio in Q3 2023.
  • Wasatch Advisors opened 17 new positions and closed 20 in Q3 2023.
  • Wasatch Advisors's portfolio value fell 4.2% quarter-over-quarter to $15.8B.

Based on Wasatch Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.